Envestnet Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Envestnet Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,490	Closed	-$387K	–	4126
2022 Q3	$387K	Buy	+7,490	New	+$310K	﹤0.01%	3195
2022 Q1	–	Sell	-6,536	Closed	-$238K	–	4100
2021 Q4	$238K	Buy	+6,536	New	+$229K	﹤0.01%	3560
2021 Q2	–	Sell	-7,674	Closed	-$393K	–	3726
2021 Q1	$393K	Buy	7,674 +3,964	+107%	+$238K	﹤0.01%	2988
2020 Q4	$230K	Sell	3,710 -613	-14%	-$35.1K	﹤0.01%	3063
2020 Q3	$237K	Buy	4,323 +547	+14%	+$29.4K	﹤0.01%	2833
2020 Q2	$217K	Buy	+3,776	New	+$205K	﹤0.01%	2838

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Envestnet Asset Management's CCXI Position: Q4 2022 in Review

Envestnet Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 7,490 shares — an estimated $387K sold.

Envestnet Asset Management first reported a position in CCXI in Q2 2020 and held it in 6 quarters. The position peaked at $393K in Q1 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Envestnet Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Envestnet Asset Management sold 7,490 ChemoCentryx, Inc. shares in Q4 2022, an estimated $387K.
Envestnet Asset Management first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 6 quarters.
Envestnet Asset Management's ChemoCentryx, Inc. position peaked at $393K in Q1 2021.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Envestnet Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.